[(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate

C30H46O7 — CID 102184941

IUPAC[(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate
SMILESCOC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](OC(=O)CCC(=O)CO)CC4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C30H46O7/c1-18(5-9-26(34)36-4)22-7-8-23-28-24(12-14-30(22,23)3)29(2)13-11-20(32)15-19(29)16-25(28)37-27(35)10-6-21(33)17-31/h18-19,22-25,28,31H,5-17H2,1-4H3/t18-,19?,22-,23+,24+,25-,28+,29+,30-/m1/s1
InChIKeyPYYVCVREWSYILL-LTRPJSEGSA-N
MW518.69 g/mol
LogP4.67
Rot. Bonds9

About [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate

[(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate (PubChem CID 102184941) has the molecular formula C30H46O7 and a molecular weight of 518.69 g/mol. Its IUPAC name is [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate.

Molecular Properties

Compound Name[(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate
PubChem CID102184941
Molecular FormulaC30H46O7
Molecular Weight518.69 g/mol
Exact Mass518.32
IUPAC Name[(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate
SMILESCOC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](OC(=O)CCC(=O)CO)CC4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C30H46O7/c1-18(5-9-26(34)36-4)22-7-8-23-28-24(12-14-30(22,23)3)29(2)13-11-20(32)15-19(29)16-25(28)37-27(35)10-6-21(33)17-31/h18-19,22-25,28,31H,5-17H2,1-4H3/t18-,19?,22-,23+,24+,25-,28+,29+,30-/m1/s1
InChIKeyPYYVCVREWSYILL-LTRPJSEGSA-N
XLogP4.67
TPSA106.97 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500518.69
LogP ≤ 54.67
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate?
The IUPAC name of [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate (CID 102184941) is [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate.
What is the SMILES notation for [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate?
The canonical SMILES for [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate is COC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](OC(=O)CCC(=O)CO)CC4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate?
The InChIKey is PYYVCVREWSYILL-LTRPJSEGSA-N. The full InChI is InChI=1S/C30H46O7/c1-18(5-9-26(34)36-4)22-7-8-23-28-24(12-14-30(22,23)3)29(2)13-11-20(32)15-19(29)16-25(28)37-27(35)10-6-21(33)17-31/h18-19,22-25,28,31H,5-17H2,1-4H3/t18-,19?,22-,23+,24+,25-,28+,29+,30-/m1/s1.
What are the key properties of [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate?
[(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate has a molecular weight of 518.69 g/mol, XLogP of 4.67, 9 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [(7R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-methoxy-5-oxopentan-2-yl]-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl] 5-hydroxy-4-oxopentanoate is sourced from PubChem (CID 102184941), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).